Navigation Links
Yongye Biotechnology to Present at Roth Capital 'China Comes to Vegas' Conference
Date:11/10/2008

h distributors and directly to farmers located in ten provinces throughout China.

Safe Harbor Statement

This press release contains certain statements that may include "forward looking statements." All statements other than statements of historical fact included herein are "forward-looking statements." These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involving known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including the risk factors discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on the SEC's website ( http://www.sec.gov ). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these risk factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

For more information, please contact:

Yongye Biotechnology International, Inc.

Mr. Larry Gilmore-VP of Corporate Strategy

Phone: +86-8232-8866 x8880

Email: larry.gilmore@gmail.com

CCG Investor Relations, Inc.

Mr. Crocker Coulson, President

Phone: +1-646-213-1915 (New York)

Email: crocker.coulson@ccgir.co
'/>"/>

SOURCE Yongye Biotechnology International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
2. Yongye Biotechnology International Raises $9.4 Million in Private Placement
3. Yongye Biotechnology International Announces Second Quarter Results
4. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
5. Yongye Biotechnology International Retains CCG Investor Relations
6. Yongye Biotechnology International, Inc. Appoints New Independent Auditor
7. Yongye Biotechnology Completes Reverse Merger and Completes $10.0 Million Private Financing
8. InNexus Biotechnology Announces New EGFR Antibody DXL1218 Targeting Colorectal Cancer and Announces $1.25 Million Private Placement
9. InNexus Biotechnology Receives Patent Grants in Europe
10. InNexus Biotechnology CEO to Present at the 7th Annual BIO Investor Forum
11. TechConnect World 2009 Matches Tomorrows Technology Solutions with Todays Business Needs for Clean-Technology, Biotechnology and Nanotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... BioPlus Specialty Pharmacy (BioPlus) announces the hiring ... of Managed Care. In this role, Damm will build ... nation’s leading specialty pharmacies. , Damm, who is based ... pharmacy and biotech experience to his new position with ... and Pfizer. Prior to working in Healthcare Damm served ...
(Date:3/5/2015)... DIEGO and TORONTO , ... TSX: APS), a clinical-stage company developing new therapeutics and ... today announced that William G. Rice , Ph.D., ... the upcoming 27th Annual ROTH Conference on Tuesday, March ... The Ritz Carlton, Laguna Niguel, CA. ...
(Date:3/5/2015)... 2015  In response to the incorrect assertions by ... on February 12, 2015. Impeto Medical SAS ... health and their SUDOSCAN® devices have been proven to ... prefers to have the courts decide this dispute rather ... 40 articles written by Key Opinion Leaders, published by ...
(Date:3/5/2015)... RMI specializes in ... conditions such as meniscal tears, ACL injuries, rotator ... pain due to degenerative conditions like osteoarthritis. ... to promote better post-surgical outcomes. , Stemnexa combines ... bone marrow harvesting with two complimentary cellular technologies: ...
Breaking Biology Technology:BioPlus Specialty Pharmacy Announces Hiring of New Vice President of Managed Care: Jamie Damm 2Aptose Biosciences to Present at the 27th Annual ROTH Conference 2Aptose Biosciences to Present at the 27th Annual ROTH Conference 3Impeto Medical Responds to Published Allegations by LD Technology LLC ("LD") 2Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 2Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 3Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 4Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 5
... Inc., (Nasdaq:,BLUD), a global leader in providing automated ... today the FDA notified the,company that it has ... Immucor,s proposed corrective actions appear to be,adequate. The ... of those corrective actions, as well as Immucor,s ...
... Biosolutions, Inc, a worldwide,supplier for porcine liver esterase has ... of over 150 million units per batch size., ... high,purity enzymes and related proteins to major diagnostic companies ... urine infection. Porcine liver,esterase is also used on a ...
... along entire poultry processing ... line, including post-chill., SHREVEPORT, ... recently confirmed that,poultry processing plants using FreshFx to acidify the ... know that adding FreshFx to the scalder can result in ...
Cached Biology Technology:FDA Accepts Immucor's Response to Warning Letter 2Increased Capacity For Porcine Liver Esterase 2FreshFx(R) in Scalder Reduces Pathogens in Evisceration 2FreshFx(R) in Scalder Reduces Pathogens in Evisceration 3
(Date:2/5/2015)... PARK, N.C. , Feb. 5, 2015  Marken ... specialist logistics company and has launched a new marketing ... Clinical Logistics Organization (CLO).  The new campaign focuses on ... on patient, protocol and shipments. The first ... , aligns Marken,s priorities with its client,s priorities. ...
(Date:2/5/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD and ... focused on the growing mobile commerce market, announces it ... Conference on January 29 th at 10:30 a.m. ... of NXT-ID will present and host a live Q&A ... and its full suite of biometric technologies. Investors can ...
(Date:1/22/2015)... Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased to inform ... State of Washington,s Department of Licensing, in the ... issuance system for driver,s licenses and identification cards to its ... development will start in January 2015, with enrollment and card ...
Breaking Biology News(10 mins):Marken Launches New Patient-Centric Campaign 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Valid USA Signs Contract For Washington Driver's License Issuance 2
... to attack an aggressive form of childhood leukemia, a ... patient, who faced grim prospects when she relapsed after ... cells, custom-designed to multiply rapidly in the patient, and ... doctors found that she had no evidence of cancer. ...
... newborn fruit fly larva ever-so-gently with a freshly plucked eyelash, ... movementan observation that has helped scientists at the University of ... touch, one of the most fundamental but least well understood ... is known to develop early and to remain ever-present in ...
... at Emory University School of Medicine have obtained a ... off key immune system genes. The finding could ... anti-inflammatory drugs with fewer side effects. The results ... journal Nature Structural & Molecular Biology . ...
Cached Biology News:Engineered immune cells produce complete response in child with an aggressive pediatric leukemia 2Engineered immune cells produce complete response in child with an aggressive pediatric leukemia 3Secrets of gentle touch revealed 2Secrets of gentle touch revealed 3Steroid hormone receptor prefers working alone to shut off immune system genes 2
The Holten Horizontal series of laminar airflow work benches offers comfort and ease of use....
The 891 45° Fixed Angle Rotor is designed to provide aerosol containment and can be removed from a centrifuge (seal entact) and opened under an environmental hood....
... images with any of UVP's Doc-It systems. ... Doc-It 1D Analysis software onto your existing ... analysis functions and enhancement tools. Doc-It 1D ... finding algorithms for quick and accurate electrophoresis ...
... 384, compatible with hood ... handling system for 384-well ... accurately prepares large quantities ... The Wellpro also performs ...
Biology Products: